ReviewClinical pharmacology and therapeutics2013
CYP2D6 genotype should not be used to determine endocrine therapy in postmenopausal breast cancer patients.
J M RaePubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it